Back to Journals » Drug Design, Development and Therapy » Volume 10
Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]
Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535.
In “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published May 2015, on page 2530, in Table 1 we have mistakenly stated the fluocinolone acetonide (FA) intravitreal inserts as Retisert® in the Campochiaro et al study; they were in fact the fluocinolone acetonide intravitreal inserts. We feel sorry about that, and we will be more rigorous to avoid any unnecessary confusion in the future.
Read the original article
© 2016 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.